(Q45068181)

9 December 2017

title

Enhancement of immunogenicity of an HIV Env DNA vaccine by mutation of the Tyr-based endocytosis motif in the cytoplasmic domain (English)

1 reference

9 December 2017

Zhigao Bu

1

1 reference

9 December 2017

Ling Ye

2

1 reference

9 December 2017

Andrei Vzorov

3

1 reference

9 December 2017

Dahnide Taylor

4

1 reference

9 December 2017

Richard W Compans

5

1 reference

9 December 2017

Chinglai Yang

6

1 reference

9 December 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

9 December 2017

1 reference

9 December 2017

volume

328

1 reference

9 December 2017

issue

1

1 reference

9 December 2017

page(s)

62-73

1 reference

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

Basolateral sorting of the HIV type 2 and SIV envelope glycoproteins in polarized epithelial cells: role of the cytoplasmic domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

A membrane-proximal tyrosine-based signal mediates internalization of the HIV-1 envelope glycoprotein via interaction with the AP-2 clathrin adaptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

Enhancement of immune responses to an HIV env DNA vaccine by a C-terminal segment of listeriolysin O.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

Identification of two sequences in the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein that inhibit cell surface expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

The membrane-proximal tyrosine-based sorting signal of human immunodeficiency virus type 1 gp41 is required for optimal viral infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

HIV-1 membrane fusion: targets of opportunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

Characterization of MHC class II-presented peptides generated from an antigen targeted to different endocytic compartments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

The Role of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins in Virus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

In vivo attenuation of simian immunodeficiency virus by disruption of a tyrosine-dependent sorting signal in the envelope glycoprotein cytoplasmic tail

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

Codon usage limitation in the expression of HIV-1 envelope glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

Prospects for vaccines to protect against AIDS, tuberculosis, and malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

The membrane-proximal intracytoplasmic tyrosine residue of HIV-1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

Endocytosis in viral replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

Identification of a calmodulin-binding and inhibitory peptide domain in the HIV-1 transmembrane glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

Challenges and opportunities for development of an AIDS vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

Interaction of endocytic signals from the HIV-1 envelope glycoprotein complex with members of the adaptor medium chain family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

Palmitoylation of the HIV-1 envelope glycoprotein is critical for viral infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

An internalization signal in the simian immunodeficiency virus transmembrane protein cytoplasmic domain modulates expression of envelope glycoproteins on the cell surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

Endocytosis of major histocompatibility complex class I molecules is induced by the HIV–1 Nef protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

Effect of the cytoplasmic domain of the simian immunodeficiency virus envelope protein on incorporation of heterologous envelope proteins and sensitivity to neutralization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

Mutation of the dominant endocytosis motif in human immunodeficiency virus type 1 gp41 can complement matrix mutations without increasing Env incorporation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

The highly conserved C-terminal dileucine motif in the cytosolic domain of the human immunodeficiency virus type 1 envelope glycoprotein is critical for its association with the AP-1 clathrin adaptor [correction of adapter]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

The human and simian immunodeficiency virus envelope glycoprotein transmembrane subunits are palmitoylated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

7 January 2021

Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

7 January 2021

Polarized human immunodeficiency virus budding in lymphocytes involves a tyrosine-based signal and favors cell-to-cell viral transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

7 January 2021

A large deletion in the matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

7 January 2021

The carboxy terminus of human immunodeficiency virus type 1 gp160 limits its proteolytic processing and transport in transfected cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

7 January 2021

Apoptosis induction by the binding of the carboxyl terminus of human immunodeficiency virus type 1 gp160 to calmodulin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

7 January 2021

The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

7 January 2021

Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.041

7 January 2021

10.1016/J.VIROL.2004.06.041

Identifiers

DOI

1 reference

9 December 2017

1 reference